Risk factors for breast cancer and expression of insulin-like growth factor-2 (IGF-2) in women with breast cancer in Wuhan city, China

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Qiu, Jun ^a   Yang, Rong ^b   Rao, Yanhua ^c   Du, Yukai ^a   Kalembo, Fatch W ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Centre of Wuhan City Maternal and Child Health Care   (China)

^c Center of Jiangxia District Maternal and Child Health Care   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; BREAST TUMOR; CANCER RISK; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; COPING BEHAVIOR; CYTOPLASM; FAMILY HISTORY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INDUCED ABORTION; MAJOR CLINICAL STUDY; OCCUPATION; PARITY; PROTEIN EXPRESSION; QUESTIONNAIRE; RISK REDUCTION; SHIFT WORKER; SLEEP; SOCIAL SUPPORT;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; INSULIN-LIKE GROWTH FACTOR II; MIDDLE AGED; RISK FACTORS;

EID: 84861464145     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036497     Document Type: Article

References (37)

1. Munagala R, Aqil F, Gupta RC, (2010) Promising molecular targeted therapies in breast cancer. Indian Journal of Pharmacology 43: 236-245.
2. Ferlay J, Shin FJ, Bray F, Forman D, Mathers C, et al. (2010) Estimate of worldwide burden of cancer in 2008. Int J Cancer 127: 2893-917.
3. Hulka BS, Moorman PG, (2001) Breast cancer: hormones and other risk factors. Maturitas 38: 103-116.
4. Kristensen VN, Borresen-Dale AL, (2000) Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism. Mutation Research 462: 323-333.
5. Kang HJ, Kim SW, Ahn SJ, Bae JY, Park SK, et al. (2002) Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk. Cancer Letters 178: 175-180.
6. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, et al. (1998) Circulating concentrations of insulin like growth factor-I and risk of breast cancer. Lancet 351: 1393-1396.
7. Schernhammer ES, Holly JM, Pollak MN, Hankinson SE, (2005) Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 699-704.
8. Renehan AG, Harvie M, Howell A, (2006) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat 3: 273-278.
9. Richardson AE, Hamilton N, Davis W, Brito C, De León D, (2011) Insulin-like Growth Factor-2 (IGF-2) Activates Estrogen Receptor-α and-β via the IGF-1 and the Insulin Receptors in Breast Cancer Cells. Growth Factors 29: 82-93.
10. American Joint Committee on Cancer: Breast (1980) Handbook for Staging of Cancer Philadelphia Lippincott.
11. Wolk A, Gridley G, Svensson M, Nyren McLaughlin JK, et al. (2001) A prospective study of obesity and cancer risk. Cancer Causes Control 12: 13-21.
12. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, et al. (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278: 1407-1411.
13. Harvie M, Howell A, Vierkant RA, Kumar N, Cerhan JR, et al. (2005) Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 14: 656-661.
14. Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, et al. (2006) Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295: 629-642.
15. Lie JA, Roessink J, Kjærheim K, (2006) Breast cancer and night work among Norwegian nurses. J Cancer Causes and Control 17: 39-44.
16. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, et al. (2001) Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 93: 1563-1568.
17. Molloy CA, May FE, Westley BR, (2000) Insulin receptor substrate expression is regulated by estrogen in the MCF27 Human breast cancer cell line. J Bio Chem 275: 12565-12571.
18. Kotsopoulos J, Lubinski J, Lynch HT, Neuhausen SL, Ghadirian P, et al. (2005) Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Cancer Causes and Control 16: 667-674.
19. Turner-Cobb JM, Sandra E, Sephton SE, Koopman C, Blake-Mortimer J, et al. (2000) Social Support and Salivary Cortisol in Women with Metastatic Breast Cancer. Journl of Psychosomatic Medicine 62: 337-345.
20. Schernhammer ES, Holly JM, Pollak MN, Hankinson SE, (2005) Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 699-704.
21. Renehan AG, Harvie M, Howell A, (2006) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer 3: 273-278.
22. Rosen N, Yee D, Lippman ME, Paik S, Cullen KJ, (1991) Insulin-like growth factors in human breast cancer. Breast Cancer Res Treat 18: S55-S62.
23. Renehan AG, Harvie M, Howell A, (2006) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk. EndocrRelat Cancer 3: 273-278.
24. Soares MR, Huber J, Rios AF, (2010) Investigation of IGF2/ApaI and H19/RsaI polymorphisms in patients with cutaneous melanoma. Growth Hormone & IGF Research 20: 295-297.
25. Grbeša I, Ivkić M, Pegan B, Gall-Trošelj K, (2006) Loss of imprinting and promoter usage of the IGF2 in laryngeal squamous cell carcinoma. Cancer Letters 238: 224-229.
26. Muller S, Zirkel D, Westphal M, Zumkeller W, (2000) Genomic imprinting of IGF2 and H19 in human meningiomas. European Journal of Cancer 36: 651-655.
27. Hankinson SE, Schernhammer ES, (2003) Insulin-like growth factor and breast cancer risk: evidence from observational studies. Breast Diseases 17: 27-40.
28. Ravenel JD, Broman WK, (2001) Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of wilms tumor. Journal of the National Cancer Institute 92: 1698-1703.
29. Giani C, Campani D, Rasmussen A, Fierabracci P, Miccoli P, et al. (2002) Insulin-like growth factor II (IGF-II). Immunohistochemistry in breast cancer: relationship with the most important morphological and biochemical prognostic parameters. Int J Biolog Mark 17: 90-95.
30. Shetty PJ, Movva S, Pasupuleti N, (2011) Regulation of IGF2 transcript and protein expression by altered methylation in breast cancer. J Cancer Res Clin Oncol 137: 339-345.
31. De Myets P, (1994) The structural basis of insulin and insulin-like growth factor-1 receptor binding and negative cooperativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 37: S135-S148.
32. Morrione A, Valentinis B, Xu SQ, Yumet G, Louvi A, et al. (1997) IGF-II stimulates cell proliferation through the insulin receptor, Proc. Natl Acad Sc 94: 3777-3782.
33. Sciacca L, Costantino A, Pandini G, Mineo R, Frasca F, et al. (1999) Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene 18: 2471-2479.
34. Visual D, Bosma A, Vrieling A, Rookus M, Veer L, (2004) IGF system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk. Breast Cancer Res Treat 84: 225-233.
35. Pacher M, Seewald MJ, Mikula M, Oehler S, Mogg M, (2007) Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells. Carcinogenesis 28: 49-59.
36. Kaaks R, (2001) Plasma insuline, IGF-I et cancer du sein Plasma insulin, IGF-I and breast cancer. Gynécol Obstét Ferti 29: 185-191.
37. LeRioth D, Roberts CT, (2003) The insulin2 like growth factor system and cancer. Cancer Lett 195: 127-13.